⚠️ This AI-generated report synthesizes publicly available information. AI can make mistakes. Please double check information in this report.
Consumer Defensive | Household & Personal Products
📊 THE BOTTOM LINE
Colgate-Palmolive is a stable consumer defensive company with leading global brands in oral, personal, and home care, and a strong pet nutrition segment. Its extensive international reach and consistent profitability underpin a resilient business model, though growth may be moderate.
⚖️ RISK VS REWARD
At current levels, CL appears fairly valued, trading slightly above its average analyst target. The stock offers defensive stability and a consistent dividend, with potential upside from strategic brand investments. Downside risks include intense competition and currency fluctuations in international markets.
🚀 WHY CL COULD SOAR
⚠️ WHAT COULD GO WRONG
Oral Care
45%
Toothpastes, toothbrushes, mouthwash, under brands like Colgate, Darlie.
Pet Nutrition (Hill's)
20%
Specialty pet food for nutritional and therapeutic needs of pets.
Personal & Home Care
35%
Soaps, shampoos, deodorants, dishwashing detergents, and household cleaners.
🎯 WHY THIS MATTERS
This diversified revenue model, heavily weighted towards essential consumer goods, provides stability and resilience across economic cycles. The strong international presence further mitigates regional market risks, ensuring consistent demand for everyday products.
Colgate-Palmolive boasts a portfolio of globally recognized brands such as Colgate, Palmolive, and Hill's. These brands have built decades of consumer trust, leading to strong loyalty and repeat purchases for essential daily products. This equity allows for premium pricing power and resilience during economic downturns, making it difficult for new entrants to compete effectively on brand alone.
Operating in over 200 countries, Colgate-Palmolive has cultivated an unparalleled distribution network encompassing traditional retail, e-commerce, wholesalers, and specialized channels like veterinarians for Hill's. This vast reach ensures product availability and visibility globally, creating a significant barrier to entry for smaller competitors and a complex logistical challenge for large rivals to replicate efficiently.
Colgate-Palmolive consistently invests in research and development, particularly in oral care and pet nutrition, to introduce innovative products that meet evolving consumer needs and scientific advancements. This commitment ensures its brands remain relevant, capture new market segments (e.g., specialized oral health, therapeutic pet foods), and maintain a competitive edge over generic or less innovative offerings.
🎯 WHY THIS MATTERS
These advantages collectively establish a robust competitive moat for Colgate-Palmolive. The combination of trusted global brands, extensive market reach, and continuous innovation enables the company to maintain market leadership, command pricing power, and deliver consistent financial performance in the highly competitive consumer goods sector.
Noel Wallace
Chairman, President & CEO
Noel Wallace has served as CEO since 2019 and was elected Chairman in 2020. His long tenure within the company, including roles in various global operations, provides deep industry knowledge. He is focused on driving growth through strategic investments and maintaining a strong competitive position.
The household and personal products industry is highly competitive, dominated by a few global players and numerous regional brands. Competition is intense across product categories, driven by pricing, product innovation, brand strength, and extensive marketing efforts. Consumers often choose based on perceived value, brand loyalty, and product efficacy.
📊 Market Context
Competitor
Description
vs CL
Procter & Gamble (PG)
A global leader in consumer goods with diverse brands in beauty, grooming, health care, fabric & home care, and baby, feminine & family care.
Direct competitor in oral care (Crest), personal care (Gillette), and home care (Dawn, Tide). Larger scale and broader portfolio.
Unilever PLC (UL)
A multinational consumer goods company offering food & refreshments, home care, and beauty & personal care products globally.
Competes in personal care (Dove, Axe, Ponds) and home care (Surf, Cif). Strong presence in emerging markets, similar global footprint.
Johnson & Johnson (JNJ)
A global healthcare giant with segments in consumer health, pharmaceuticals, and medical devices. Consumer health includes oral care, baby care, and skin health.
Competes in oral care (Listerine) and personal care (Aveeno, Neutrogena). More diversified, but consumer segment is a smaller part of overall business.
Colgate-Palmolive
40%
Procter & Gamble
20%
Unilever
15%
Others
25%
1
6
8
5
Low Target
US$77
-1%
Average Target
US$87
+12%
High Target
US$95
+22%
Current: US$78.07
High Probability
Morningstar notes that prudent brand spending could reignite sluggish sales growth, leading to market share gains and revenue acceleration, especially in key product categories and emerging markets.
High Probability
Colgate's focus on stringent cost management is expected to buttress its competitive edge. This improved operational efficiency can expand profit margins and increase overall profitability in a competitive environment.
Medium Probability
The Hill's Pet Nutrition segment continues to be a strong performer, providing stable growth and higher margins. Ongoing innovation and expansion within this specialized market offer a consistent growth driver for the company.
High Probability
The consumer defensive sector faces intense competition, which can lead to aggressive pricing strategies and promotional activities. This pressure could erode profit margins across various product lines and negatively impact market share.
Medium Probability
A significant portion of Colgate-Palmolive's revenue is generated in international markets. Adverse currency fluctuations and economic instability in these regions can directly reduce reported earnings and hinder sales growth.
Medium Probability
Rapid shifts in consumer preferences towards niche, local, or 'clean label' brands pose a challenge to established global brands. Failure to adapt quickly could necessitate significant investment in R&D and marketing, impacting profitability.
Colgate-Palmolive exhibits characteristics of a stable long-term holding due to its robust portfolio of essential consumer brands, extensive global distribution, and consistent dividend payments. While growth may be moderate, its strong brand equity and ability to innovate in key categories like oral and pet care provide a durable competitive advantage. Maintaining market relevance amidst evolving consumer trends and managing foreign exchange volatility are long-term considerations.
Metric
FY 2022
FY 2023
FY 2024
FY 2025 (Est)
FY 2026 (Est)
Income Statement
Revenue
US$17.97B
US$19.46B
US$20.10B
US$20.10B
US$20.48B
Gross Profit
US$10.25B
US$11.33B
US$12.16B
US$12.09B
US$12.32B
Operating Income
US$3.62B
US$4.08B
US$4.33B
US$4.34B
US$4.42B
Net Income
US$1.78B
US$2.30B
US$2.89B
US$2.91B
US$2.94B
EPS (Diluted)
2.13
2.77
3.51
3.57
3.61
Balance Sheet
Cash & Equivalents
US$0.78B
US$0.97B
US$1.10B
US$1.28B
US$1.28B
Total Assets
US$15.73B
US$16.39B
US$16.05B
US$17.51B
US$17.51B
Total Debt
US$9.27B
US$9.06B
US$8.51B
US$8.42B
US$8.42B
Shareholders' Equity
US$0.40B
US$0.61B
US$0.21B
US$0.86B
US$0.86B
Key Ratios
Gross Margin
57.0%
58.2%
60.5%
60.1%
60.1%
Operating Margin
20.1%
21.0%
21.5%
21.6%
21.6%
Return on Equity (TTM)
445.14
377.67
1362.74
293.64
293.64
| Metric | Value | Description |
|---|---|---|
| P/E Ratio (TTM) | 21.87 | The trailing price-to-earnings ratio indicates how much investors are willing to pay per dollar of past earnings over the last twelve months. |
| Forward P/E | 20.23 | The forward price-to-earnings ratio reflects investor expectations for future earnings, based on estimated earnings for the next twelve months. |
| PEG Ratio | N/A | The Price/Earnings to Growth (PEG) ratio relates the P/E ratio to the earnings growth rate, offering a more complete picture of valuation for growth stocks. |
| Price/Sales (TTM) | 3.14 | The price-to-sales ratio measures the stock price relative to its revenue, useful for valuing companies with unstable earnings or in early growth stages. |
| Price/Book (MRQ) | 74.22 | The price-to-book ratio compares the company's market value to its book value, indicating how much investors are willing to pay for each dollar of net assets. |
| EV/EBITDA | 14.73 | Enterprise Value to EBITDA evaluates a company's total value (including debt) relative to its earnings before interest, taxes, depreciation, and amortization, often used for comparing companies with different capital structures. |
| Return on Equity (TTM) | 2.94 | Return on Equity measures the profitability of a company in relation to the equity invested by shareholders, indicating how efficiently the company is using shareholder funds to generate profits. |
| Operating Margin | 0.20 | Operating margin measures how much profit a company makes on each dollar of sales after paying for variable costs of production, such as wages and raw materials, but before interest and taxes. |
| Company | Market Cap (B) | P/E Ratio | P/B Ratio | Revenue Growth (%) | Operating Margin (%) |
|---|---|---|---|---|---|
| Colgate-Palmolive (CL) (Target) | 63.10 | 21.87 | 74.22 | 1.9% | 20.2% |
| Procter & Gamble (PG) | 353.94 | 25.59 | 7.42 | 1.5% | 23.3% |
| Unilever PLC (UL) | 134.62 | 19.55 | 6.88 | 3.1% | 16.5% |
| Johnson & Johnson (JNJ) | 381.04 | 21.90 | 4.67 | 5.4% | 29.5% |
| Sector Average | — | 22.35 | 6.32 | 3.3% | 23.1% |